Acute monocytic leukemia News and Research

RSS
Data from phase II study of Trisenox (arsenic trioxide) injection in myelodysplasia

Data from phase II study of Trisenox (arsenic trioxide) injection in myelodysplasia

Lorus Therapeutics allowed Canadian patent to protect anticancer drugs

Lorus Therapeutics allowed Canadian patent to protect anticancer drugs

Maxim Pharmaceuticals to withdraw NDA for advanced malignant melanoma

Maxim Pharmaceuticals to withdraw NDA for advanced malignant melanoma

Experimental drug PKC412 may be the key to treating myeloproliferative disease

Experimental drug PKC412 may be the key to treating myeloproliferative disease

Data suggests potential role of Quadramet in conjunction with chemotherapy for the treatment of acute myeloid leukemia

Data suggests potential role of Quadramet in conjunction with chemotherapy for the treatment of acute myeloid leukemia

Guidelines for determining the best possible time to receive bone marrow transplants

Guidelines for determining the best possible time to receive bone marrow transplants

Smoking a lot more harmful than previously thought

Smoking a lot more harmful than previously thought

Smoking causes diseases in nearly every organ of the body

Smoking causes diseases in nearly every organ of the body

FDA approves new drug for bone marrow disease

FDA approves new drug for bone marrow disease

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

Embryo testing could produce babies who might aid sick siblings

Embryo testing could produce babies who might aid sick siblings

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.